# Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women

> **NCT03669094** · NA · COMPLETED · sponsor: **ProbiSearch SL** · enrollment: 40 (actual)

## Conditions studied

- Gestational Mother
- Streptococcus Agalactiae Infection

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus salivarius V4II-90
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03669094
- **Lead sponsor:** ProbiSearch SL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-05
- **Primary completion:** 2021-08-02
- **Final completion:** 2021-10-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03669094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03669094, "Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03669094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*